Aquilón’s trajectory is a clear example of the potential of technology transfer in Spain. Over more than a decade, the company has developed innovative biological solutions to improve swine digesti...
Since its investment in 2022 through its Tech Transfer Agrifoodfund, managed by Clave Capital, MicroSalt has demonstrated strong market validation of its innovative FoodTech solution: a full-flavour n...
Founded in 2016, Uptech Sensing has established itself as one of the leading companies in DFOS (Distributed Fiber Optic Sensor) technology. This is a pioneering technology for monitoring various criti...
Founded to translate cutting-edge neuroscience research into novel ophthalmic solutions, D-Sight is developing first-in-class neuroprotective drugs aimed at preserving retinal neurons and preventing i...
These divestments materialized after an average holding period of 5.5 years, supporting founding teams and demonstrating market interest and the potential of their technological developments in areas ...
This transaction represents the company’s third acquisition and consolidates a strategy of inorganic growth carried out in a progressive and sustainable manner, following the integrations of FeelU a...
The transaction has attracted new investors such as Red Bull Ventures, Tech Transfer Agrifood, Co-Invest Capital, AttaPoll and Firstpick, and has also seen strong participation from existing investors...
Since its incorporation, Abanzamed has developed a pipeline of various fixation systems for surgeries, initially focused on the knee and now diversifying into ankle and shoulder, based on a patented t...
The entry of Angels, Capsa Food, and TTAF BY CLAVE into ODOS’s capital strengthens its business model and validates its growth potential, paving the way for initial deals with key clients. The ODOS ...
This financing is divided into three parts: equity, convertible note and bank debt. Firstly, the capital increase round amounted to 4.81 million euros and was formalised by the following companies: Ap...
Los fondos se emplearán para abordar nuevos ensayos clínicos, ampliar la estructura de la empresa, así como para la comercialización del postbiótico ‘pA1c®HI’. Basado en una cepa bacteriana ...
La gestora de capital riesgo Clave Capital ha participado en la primera ronda de inversión institucional de Homedoctor, empresa líder en medicina digital. Esta exitosa operación también ha contado...